Clinical Trial Update: MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma [NA]

View source ↗

Summary

This clinical trial update reports on MP470 for unresectable or metastatic solid tumors and lymphoma, with the study status shown as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• MP470

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: TERMINATED